InsidersTradesSigma
Discover the detailed record of transactions filed by Holmen Bob, Director. Insider active across 1 companies, notably Sensei Biotherapeutics, Inc.. Aggregated, 1 filings have been published. The latest transaction was disclosed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Bob Holmen is a Board Member at Sensei Biotherapeutics, Inc. He plays a key role in the governance of the company, which focuses on developing biopharmaceutical solutions. His experience in the sector is essential in guiding research and development initiatives and ensuring that the company remains at the forefront of innovation.